FORTE Study Updates: July 2024 Newsletter

July 11 2024

FORTE enrolled its 1700th participant on July 3, 2024!

FORTE Coordinator Session – August 7, 2024

Register for this virtual webinar to hear from sites about enrollment best practices. Bring your questions about FORTE to this webinar on NRG-CC005. Topics will include:

·         Introduction to FORTE Leadership

·         5 vs.10-year Colonoscopy

·         Onboarding New Research Staff – Data Entry, Patient Contact

·         Communication with Patients

·         Q&A Panel

·         Follow-Ups

·         Data Quality Management

·         FORTE Resource Portal

·         Q&A Panel

Remote Consent

FORTE leadership encourages sites to examine implementing remote consenting in your site’s patient enrollment processes. Since NRG-CC005 does not require an in-person visit to enroll, FORTE sites currently consent patients using platforms such as RedCap, DocuSign, and snail mail. The highest accruing sites have remote components to the enrollment, stool collection, and blood sample collection. Additionally, patients have expressed enjoying the ease of enrolling into FORTE using remote processes like RedCap.

Many institutions have re-examined policies around remote research in the past few years to accommodate changing patient expectations. Explore implementing remote consent at your enrolling site today!

If you have an questions about implementing remote consent processes for FORTE at your site, contact

There is still time to register for the NRG Summer Meeting & FORTE Workshop!

The FORTE Workshop will be in-person only on July 26 at 1:15 local time. Register today to hear updates on NRG-CC005 at the Summer Meeting!

Accrual Updates and Milestones (as of July 1, 2024)

Topaccruing sites:

Kaiser Permanente – Vallejo – 925 accrued

UPMC-Presbyterian Hospital – 230 accrued

Regions Hospital – 84 accrued

Most recent randomizations:

Centro Comprensivo de Cancer de UPR – July 1, 2024

Kaiser Permanente – Vallejo – June 28, 2024

Yale University – June 28, 2024

Memorial Health University Medical Center – June 28, 2024  

Recent Trial-Wide Monthly Accrual:

April 2024 – 90 participants

May 2024 – 115 participants

June 2024 - 102 participants

Questions from Site Research Staff

If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at:  
1(800) 477-7227

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.